Treatment outcomes of patients with superior vena cava syndrome who received high dose radiotherapy at UP - PGH from 2009 - 2011
Acta Medica Philippina
;
: 74-79, 2013.
Article
in English
| WPRIM
| ID: wpr-633685
ABSTRACT
BACKGROUND:
85% of cases of Superior Vena Cava Obstruction (SVCO) are caused by malignancy. Radiation therapy (RT) is an effective therapeutic modality for SVCO localized in the thorax, especially for obstructive causes.OBJECTIVE:
To determine the clinical profile and outcomes of patients who received radiation treatment at UP-PGH from January 1, 2009 - December 31, 2001.METHODS:
Records of patients with SVCO were reviewed. The patient's demographic profiles were collected. Outcomes were labaled as recovered, improved, not improved and died based on standard definitions. STUDYDESIGN:
Retrospective, descriptive study. STUDYSETTING:
Philippine General Hospital STUDY POPULATION UP-PGH patients with SVCO from 2009-2011.RESULTS:
The majority of the referrals were from general medicine (50%) and the most common symptom was dyspnea (73%); however, it took the patients 2-4 weeks from the onset of symptoms to seek consult. 36% of patients had lung adenocarcinoma with disseminated disease at diagnosis. The majority (73%) showed symptomatic response after receiving the SVC dose.CONCLUSION:
The importance of multidisciplinary approach to patient care cannot be overemphasized. Improvement in signs and symptoms, particularly with that of dyspnea, was noted in 72.5% of patients after receiving radiation therapy. Of the 8 patients who followed up for completion therapy, 5/8 of them reported significant improvement.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thorax
/
Superior Vena Cava Syndrome
/
Adenocarcinoma
/
Dyspnea
/
Adenocarcinoma of Lung
/
Patient Care
/
Hospitals, General
/
Lung Neoplasms
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Acta Medica Philippina
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS